Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531
Abstract
The International Neuroblastoma Risk Group (INRG) classifier utilizes a staging system based on pretreatment imaging criteria in which image-defined risk factors (IDRFs) are used to evaluate the extent of locoregional disease. Children's Oncology Group (COG) study ANBL0531 prospectively examined institutional determination of IDRF status and compared that to a standardized central review.
Keywords
NeuroblastomaPediatric OncologyImage-defined Risk FactorsIdrf AssessmentTumor StagingDiagnostic ImagingChildren's Oncology GroupHashtags
#Neuroblastoma#PediatricOncology#IDRF#TumorStagingThis article is published on an external journal. Click below to read the full text.
Read full article ↗How to cite: GlobalCastMD. Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531. GlobalCastMD Medical Library. 2024-09-05. https://library.globalcastmd.com/article/9125
Comments (0)